Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.

CONCLUSION: The preliminary evidence suggests that sirolimus may serve as an alternative treatment for patients with LN who do not tolerate standard treatment or who had a history of malignancy, and it has an acceptable longterm safety profile. PMID: 30275264 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30275264?dopt=Abstract

Source: J Rheumatol - October 1, 2018 Category: Rheumatology Authors: Yap DYH, Tang C, Chan GCW, Kwan LPY, Ma MKM, Mok MMY, Chan TM Tags: J Rheumatol Source Type: research